* A corporate client of Hybridan LLP

** Arranged by type of listing and date of announcement

*** Alphabetically arranged

**** Potential means Intention to Float (ITF) has been announced, or it is a rumour


Dish of the day

 

What’s baking in the oven? **

Banquet Buffet***

 

Clean Invest Africa 0.045p £0.9m (AQSE: CIA)

The investment vehicle that identifies investment opportunities and acquisitions in renewable and clean energy projects/ companies or alternative technologies, announce that it has successfully renegotiated an outstanding Loan Facility agreement with Contax Partners Inc. (beneficially owned by Filippo Fantechi) with an outstanding balance of approximately £551k. The entire debt of £551k will be immediately converted into 157,437,729 Ordinary Shares of the Company at a price of 0.35 pence per share. All Conversion Shares will be subject to a 12-month lock-in period and thereafter subject to an orderly market agreement for a further period of 12 months.

 

Cordel Group  4.45p £8.9m (CRDL.L)

The Artificial Intelligence platform for transport corridor analytics, announces that it has extended its relationship with Amtrak through the award of a contract to provide a comprehensive assessment of Amtrak's Metro-North corridor. Metro-North serves the New York Metropolitan Area, running services between New York City and its northern suburbs in New York and Connecticut.  It is part of the Northeast Corridor (NEC), an electrified railroad line in the Northeast megalopolis of the United States, running from Boston in the north to Washington, D.C. in the south. The contract extension builds upon Cordel's ongoing work with Amtrak and aims to enhance safety and efficiency on this critical rail line.

 

Firering Strategic Minerals 2.95p £5.4m (FRG.L)

The development company focusing on critical minerals announces that an agreement with a multinational commodity trading company has been signed, which will provide a logistics services revenue stream at Limeco, its advanced quicklime project in Zambia. This two year agreement providing expected revenue of US$600-720k per annum. This means that Limeco is producing positive operational cashflow even before start of core quicklime production in Q4 2024. Negotiations are ongoing with major copper producers for the sale of quicklime.  Aggregate sales began in Q4 2023 with further offtake agreements expected as operations ramp up in the coming months. Firering currently holds a 20.5% stake in Limeco Resources Limited.

 

Frontier IP Group 32.5p £18.3m (FIPP.L)

The specialist in commercialising intellectual property announces that portfolio company GraphEnergyTech has raised £1m through its first external equity funding round. The fundraising was led by Aramco Ventures, the corporate venturing arm of Aramco, the world's leading integrated energy and chemicals company. Frontier IP, a GraphEnergyTech co-founder, now holds a 23.97% equity stake. Proceeds will be used to accelerate development and scale up of GraphEnergyTech's advanced high-conductivity graphene electrodes. The technology's initial application is for use in solar cells, where graphene can replace silver electrodes.

 

Gunsynd 0.16p £0.9m (GUN.L)

The investing company announces that, further to the announcement of 11 July 2024, it has entered into a farm-in agreement with Pinwheel Resources Ltd in relation to certain licences over prospective acreage in Canada. Gunsynd has acquired a 100% legal and beneficial interest in the Falcon Lake U-Cu-Co project and Bear-Twit VMS project in Canada and consideration of £200,000 will be satisfied by (i) the issue of 115,384,615 new ordinary shares at a price of 0.13 pence per share for a total consideration of £150,000; (ii) £50,000 in cash (£25,000 paid on completion, £25,000 deferred to the earlier of: (a) 10 business days after completion of a qualifying fundraise of at least £200,000, or (b) the first anniversary of the Agreement.

 

hVIVO plc 29.5p £200.7m (HVO.L)

The fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its intention to cancel its admission to trading on Euronext Growth. As hVIVO’s primary operations, along with the majority of its employees and investor base, are in the UK, the Board has decided to consolidate trading of the Company’s stock to its primary listing on the AIM Market. The Cancellation will also remove certain costs, complexities and duplication that comes from administering two listing regimes and will have no impact on hVIVO’s Ordinary Shares which will continue to trade on AIM under the ticker “HVO”.

 

IXICO plc 7p £3.4m (IXI.L)

The precision analytics company delivering intelligent insights in neuroscience, announces that Bram Goorden will be appointed as Chief Executive Officer of the Company from 19 August 2024. Bram has over 20 years leadership experience in BioPharma and precision medicine, serving in roles where he has been instrumental in shaping commercial strategies for scale, growing revenues and ultimately enabling realisation of shareholder value. He has strong CNS experience, and established networks within IXICO's target market.

 

Mindflair plc 1.075p £2.9m (MFAI.L)

The company that invests in next-generation technology focused on AI, announces that it has agreed to subscribe £300k for 315,790 new shares in Sure Ventures plc at a price of 95 pence per share. Prior to the Subscription, Mindflair held 1,501,000 ordinary shares in SV plc, representing a 20.5% shareholding  which it acquired in February 2021 through the issue of its own equity at a price of 13.6 pence per share. Sure Ventures plc's principal asset is a 25.9 % shareholding in Sure Valley Ventures Fund (SVV1).  Mindflair already has a 13% direct interest in SVV1 and a 5.3% indirect interest in SVV1 via its current holding in Sure Ventures plc.  SVV1 is both closed to new investment and has entered its realisation phase. In addition, the Subscription has also increased the Company's indirect interest in the Sure Valley Ventures UK Software Technology Fund (SVV2).

 

Real Estate Investors 34p £59.3m (RLE.L)

The UK's only Midlands-focused Real Estate Investment Trust (REIT), with a portfolio of commercial property across all sectors, provides a trading update. Planned disposals were £11.9m year-to-date, either completed (or conditionally exchanged) at an aggregate uplift of 4.1% (before costs) against December 2023 valuations. Receipts from completed disposals have been used to repay £7.3m of debt year-to-date. Total cash at bank is £4.4m, with monies on deposit earning 4.5%. Average cost of debt maintained at 6.5% (FY 23: 6.5%). Contracted rental income was £10m p.a. (FY23: £10.9m p.a.) with loss of income predominantly due to disposals and concluding vacant possession on specific assets to satisfy contractual sales obligations.

 

Windar Photonics  48.5p £39.4m (WPHO.L)

The technology group that has developed its WindEye and WindTimizer LiDAR wind sensors and its related 'Nexus' software suite designed to increase the power output and reduce lifetime operating costs of wind turbines, gives an update ahead of its AGM today. Windar Photonics provided a trading update, alongside the 2023 final results announcement, on 1st July. Since then, the Company has received a new order from a Canadian client  to test our WindEye product on the Senvion turbine platform, starting in September. While the value of this test order, which includes the use of supporting software, is not in itself material, the Board anticipates that if the test is successful, this could lead to potentially significant new orders.

 

Status of this Note and Disclaimer

This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II       Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).

This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii)  persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.